D2G Oncology, Inc.
Biotechnology company · Mountain View, California, United States
D2G Oncology, Inc. is a biotechnology company headquartered in Mountain View, California, United States. Its earliest recorded incorporation is in 2018. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $8.7 million sold in a notice filed in 2020.
D2G Oncology at a glance
What does D2G Oncology do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $2 million in total (2020). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $8.7 million sold (2020).
Frequently asked questions about D2G Oncology
Where is D2G Oncology headquartered?
D2G Oncology, Inc. is headquartered in Mountain View, California, United States.
What does D2G Oncology do?
D2G Oncology, Inc. is a biotechnology company.
When was D2G Oncology founded?
The earliest incorporation on record for D2G Oncology, Inc. is in 2018, according to public company registers.
Similar companies
- Specific Diagnostics, Inc.Mountain View, California, United States
- Cytorum, Inc.Mountain View, California, United States
- 23ANDME, Inc.Mountain View, California, United States
- AvironMountain View, California, United States
- Edison Pharmaceuticals IncMountain View, California, United States
- NeuroQore, Inc.Mountain View, California, United States
- Osel, Inc.Mountain View, California, United States
- Kinetic River Corp.Mountain View, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences